Cargando…
Controlling Cancer Cell Death Types to Optimize Anti-Tumor Immunity
Over several decades, cell biology research has characterized distinct forms of regulated cell death, identified master regulators such as nuclear factor kappa B (NFκB), and contributed to translating these findings in order to improve anti-cancer therapies. In the era of immunotherapy, however, the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138898/ https://www.ncbi.nlm.nih.gov/pubmed/35625711 http://dx.doi.org/10.3390/biomedicines10050974 |